Showing results (1-10 of 17) with videos related to
Sort By:
Pageof 2
Clinical and Translational Science|November 2, 2019
Pivotal Considerations for Optimal Deployment of Healthy Volunteers in Oncology Drug DevelopmentMariam A Ahmed, Chirag Patel, Nicole Drezner, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 6, 2025
Dosage Optimization of Pediatric Oncology Products: Our Patients Deserve BetterKristin M Wessel, Nicole Drezner, Stacy S Shord, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 2, 2026
Considerations for Clinical Trial Design in Relapsed and Refractory Osteosarcoma: An FDA SymposiumKristin M Wessel, Katherine A Janeway, Lara E Davis, et al.The Oncologist|February 13, 2024
Impact of Increasing PD-L1 Levels on Outcomes to PD-1/PD-L1 Inhibition in Patients With NSCLC: A Pooled Analysis of 11 Prospective Clinical TrialsJonathon Vallejo, Harpreet Singh, Erin Larkins, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 17, 2026
Selpercatinib and the Crossover Conundrum: Potential Impact of Postprogression Therapies on Overall SurvivalElizabeth S Duke, Diana Bradford, Arup K Sinha, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 4, 2023
US Food and Drug Administration Approval Summary: Nivolumab Plus Platinum-Doublet Chemotherapy for the Neoadjuvant Treatment of Patients With Resectable Non-Small-Cell Lung CancerOladimeji Akinboro, Nicole Drezner, Anup Amatya, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 14, 2021
FDA Approval Summary: Sotorasib for KRAS G12C-Mutated Metastatic NSCLCErica C Nakajima, Nicole Drezner, Xiaoxue Li, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 25, 2024
US Food and Drug Administration Approval Summary: Eflornithine for High-Risk Neuroblastoma After Prior Multiagent, Multimodality TherapyElizabeth S Duke, Diana Bradford, Arup K Sinha, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 24, 2021
FDA Approval Summary: Osimertinib for Adjuvant Treatment of Surgically Resected Non-Small Cell Lung Cancer, a Collaborative Project Orbis ReviewAbigail L Koch, Paz J Vellanki, Nicole Drezner, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 23, 2023
FDA Approval Summary: Dabrafenib in Combination with Trametinib for BRAFV600E Mutation-Positive Low-Grade GliomaMichael I Barbato, Jeannette Nashed, Diana Bradford, et al.Pageof 2